Predicting Radiation-Induced Lung Injury in Patients With Lung Cancer: Challenges and Opportunities
International Journal of Radiation Oncology*Biology*Physics · 2024
DOI: 10.1016/j.ijrobp.2023.10.044 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2024. Verfasst von Merian E Kuipers und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonology, Leiden University Medical Center, Leiden, The Netherlands. Electronic address: m.e.kuipers1@lumc.nl. Hauptthemen laut MEDLINE: Lung Neoplasms, Lung Injury, Radiation Injuries. Die Arbeit wurde bisher 57-mal zitiert (Crossref) und nennt 111 Literaturangaben. Gefördert von: Leids Universitair Medisch Centrum.
Abstract (Originalsprache)
Radiation-induced lung injury (RILI) is one of the main dose-limiting toxicities in radiation therapy (RT) for lung cancer. Approximately 10% to 20% of patients show signs of RILI of variable severity. The reason for the wide range of RILI severity and the mechanisms underlying its development are only partially understood. A number of clinical risk factors have been identified that can aid in clinical decision making. Technological advancements in RT and the use of strict organ-at-risk dose constraints have helped to reduce RILI. Predicting patients at risk for RILI may be further improved with a combination of cytokine assessments, γH2AX-assays in leukocytes, or epigenetic markers. A complicating factor is the lack of an objective definition of RILI. Tools such as computed tomography densitometry, fluorodeoxyglucose-positron emission tomography uptake, changes in lung function measurements, and exhaled breath analysis can be implemented to better define and quantify RILI. This can aid in the search for new biomarkers, which can be accelerated by omics techniques, single-cell RNA sequencing, mass cytometry, and advances in patient-specific in vitro cell culture models. An objective quantification of RILI combined with these novel techniques can aid in the development of biomarkers to better predict patients at risk and allow personalized treatment decisions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pulmonology, Leiden University Medical Center, Leiden, The Netherlands. Electronic address: m.e.kuipers1@lumc.nl.
- Department of Radiotherapy, Leiden University Medical Center, Leiden, The Netherlands.
- Department of Pulmonology, Leiden University Medical Center, Leiden, The Netherlands.
Förderung
- Leids Universitair Medisch Centrum
Zitieren
APA
Kuipers, M. E., van Doorn-Wink, K. C. J., Hiemstra, P. S., & Slats, A. M. (2024). Predicting Radiation-Induced Lung Injury in Patients With Lung Cancer: Challenges and Opportunities. International Journal of Radiation Oncology*Biology*Physics. https://doi.org/10.1016/j.ijrobp.2023.10.044
Vancouver
Kuipers ME, van Doorn-Wink KCJ, Hiemstra PS, Slats AM. Predicting Radiation-Induced Lung Injury in Patients With Lung Cancer: Challenges and Opportunities. International Journal of Radiation Oncology*Biology*Physics. 2024. doi:10.1016/j.ijrobp.2023.10.044
BibTeX
@article{Kuipers2024,
author = {Kuipers, Merian E and van Doorn-Wink, Krista C J and Hiemstra, Pieter S and Slats, Annelies M},
title = {Predicting Radiation-Induced Lung Injury in Patients With Lung Cancer: Challenges and Opportunities},
journal = {International Journal of Radiation Oncology*Biology*Physics},
year = {2024},
doi = {10.1016/j.ijrobp.2023.10.044}
}
EUVIMED